Trial Details

RECRUITING
Basic Information
Clinical ID c1042
Identifier NCT06109441
Trial Title Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions BIOLOGICAL: ALTB-268
Participant Information
Sponsor AltruBio Inc.
City San Diego
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2023-12-04
Primary Completion Date 2025-10-25
Completion Date 2025-11-26